Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
99mTc-HFAPI SPECT/CT in Pulmonary Fibrosis
NCT05859763Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Dec 2021
- Primary completion
- Jul 2023
- Modality
- Radiopharmaceutical
- Countries
- 1
01
Overview
Open-label, single-arm trial of 99mTc-HFAPI in pulmonary fibrosis (PF), sponsored by Peking Union Medical College Hospital. Primary endpoint: Diagnostic accuracy at 1.5 years. Status: unknown.
02
Drugs
99mTc-HFAPI
03
Conditions
pulmonary fibrosis (PF)
Beyond the preview
Go deeper on NCT05859763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05859763.